Accurately monitor HIV-1 levels with the HIV-1 RNA PCR (Quantitative) Viral Load test for effective treatment management.
The HIV-1 RNA PCR (Quantitative) Viral Load test measures the amount of HIV-1 RNA (the genetic material of the virus) in the blood. This test uses advanced Polymerase Chain Reaction (PCR) technology to quantify the viral load, providing precise information about the level of HIV-1 in an individual's bloodstream. Unlike qualitative tests, which only confirm the presence of the virus, this quantitative test is crucial for monitoring the progression of HIV and evaluating the effectiveness of antiretroviral therapy (ART).
This test is recommended for individuals who:
Have been diagnosed with HIV-1 to monitor their viral load over time. Undergoing antiretroviral therapy to assess the treatment’s effectiveness. High risk of HIV-1 exposure, such as healthcare workers, individuals with multiple sexual partners, or those who share needles. Require baseline viral load measurement after an initial HIV-1 diagnosis.
This test plays a critical role in the management of HIV-1 infection. Monitoring viral load helps healthcare providers determine how well antiretroviral therapy is suppressing the virus. A decreasing viral load indicates successful treatment, while an increasing load may suggest drug resistance or treatment failure, prompting the need for adjustments. Early detection of viral replication also helps prevent the progression to AIDS, improves quality of life, and reduces the risk of transmitting the virus to others.
The results are typically reported in copies of HIV-1 RNA per milliliter (mL) of blood:
Undetectable Viral Load: Below the test’s detection limit, often less than 20–50 copies/mL.
Low Viral Load: Less than 1,000 copies/mL.
Moderate Viral Load: 1,000–100,000 copies/mL.
High Viral Load: Greater than 100,000 copies/mL.
An undetectable viral load is the goal of antiretroviral therapy, as it indicates effective viral suppression and lowers the risk of transmission.
You should choose Diagnopein for your HIV-1 RNA PCR (QUANTITATIVE) VIRAL LOAD test because we are committed to providing high-quality diagnostic care in a clean and hygienic environment. Our center is equipped with advanced technology to ensure accurate and reliable test results, which are crucial for assessing this test. Diagnopein’s experienced staff is dedicated to handling tests with precision and care, offering you both expertise and comfort. We also offer affordable pricing, making essential health diagnostics accessible without compromising quality. For timely, professional, and affordable cardiac testing, Diagnopein is your trusted partner for your healthcare.
Newly diagnosed patients and those starting or switching antiretroviral therapy should be tested every 3–6 months. Stable patients may require annual testing.
It is used to monitor the progression of HIV-1 infection and evaluate the effectiveness of antiretroviral therapy.
A blood sample is collected and analyzed in a laboratory using PCR technology to quantify the viral RNA.
No, undetectable means the virus is suppressed to levels that tests cannot detect. However, HIV remains in the body, and treatment must continue.
